Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

British Journal of Cancer

Volumn 75, Issue 10, 1997, Pages 1525-1533

  Dettmar, P ^a   Harbeck, N ^a,b   Thomssen, C ^a   Pache, L ^a   Ziffer, P ^a   Fizi, K ^a   Janicke F ^a   Nathrath, W ^a   Schmitt, M ^a   Graeff, H ^a   Hofler H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

MIB1 (Ki 67); Node negative breast cancer; Prognosis; Proliferation; S phase

Indexed keywords

KI 67 ANTIGEN; STEROID RECEPTOR;

ADULT; ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CELL CYCLE S PHASE; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VOLUME;

EID: 8244230511     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.261     Document Type: Article

References (42)

1. Aubele M, Auer G, Voss A, Falkmer U, Rutquist LE und Höfler H (1995) Different risk groups in node-negative breast cancer: prognostic value of cytometrically assessed DNA, morphometry and texture. Int J Cancer 63: 7-12
2. Bagwell CB, Mayo SW, Whetstone SD, Hitchcox SA, Baker DR, Herbert DJ, Weaver DL, Jones MA and Lovett EJ (1991) DNA histogram debris theory and compensation. Cytometry 12: 107-118
3. Biesterfeld S, Noll I, Noll E, Wolthmann D and Böcking A (1995) Mitotic frequency as a prognostic factor in breast cancer. Hum Pathol 26: 47-52
4. Bloom HJG and Richardson WW (1957) Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377
5. Böyum A (1968) Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest 21 (suppl. 97)
6. Cattoretti G, Becker MHG and Key G (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363
7. Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T and McGuire WL (1989) Prediction of relapse and survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320: 627-633
8. Cordell JL, Falini B, Erber W, Gatter KC and Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. J Histochem Cytochem 32: 219-229
9. Cuevas E, Jones DB and Wright DH (1993) Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 169: 477-178
10. Dervan PA, Gilmartin LG, Loftus BM and Carney DN (1989) Breast carcinoma kinetics: argyrophilic nucleolar organizer region counts correlate with Ki-67 scores. Am J Clin Pathol 92: 401-407
11. Dressler LG, Seamer LC, Owens MA, Clark GM and McGuire WL (1988) DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420-427
12. Fisher B, Slack NH, Bross IDJ and Cooperating Investigators (1969) Cancer of the breast: size of tumor and prognosis. Cancer 24: 1071-1080
13. Gasparini G, Boracchi P, Verderio P and Bevilacqua P (1994) Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry. Int J Cancer 57: 822-829
14. Gerdes J, Schwab U, Lemke H and Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20
15. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U and Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715
16. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E and Flad HD (1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138: 867-873
17. Gorczyca W, Markiewski M, Kram A, Tuziak T and Domagala W (1995) Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction. Virchows Archiv 426: 229-233
18. Graham D, Magee H, Kierce B, Ball R, Dervan P and O'Meara A (1995) Evaluation of Ki-67 reactivity in neuroblastoma using paraffin embedded tissue. Path Res Pract 191: 87-91
19. Harbeck N, Moniwa N, Busch E, Schmitt M, Jänicke F, Fellbaum C, Höfler H and Graeff H (1991) Durchfluβzytometrische DNA-Analyse von reinen Zellkernen aus formalin-fixierten paraffinschnitten beim primären Mammakarzinom: Korrelation mit anderen Prognosefaktoren. Gynäkol Rundsch 31(suppl.2): 299-302
20. Harbeck N, Yamamoto N, Moniwa N, Schüren E, Ziffer P, Dettmar P, Höfler H, Schmitt M and Graeff H (1994) Flow cytometric DNA analysis in primary breast cancer: Technical pitfalls and clinical applications. In Elsevier Science: Prospects in Diagnosis and Treatment of Breast Cancer. Schmitt et al (eds). pp. 63-74
21. Hedley DW (1989) Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 10: 229-241
22. Hedley DW, Friedlander ML, Taylor IW, Rugg CA and Musgrove EA (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333-1335
23. Hedley DW, Friedlander ML and Taylor IW (1985) Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 6: 327-333
24. Hedley DW, Rugg CA and Gelber RD (1987) Association of DNA index and S-phase fraction with prognosis of node positive early breast cancer. Cancer Res 47: 4729-4735
25. Isola JJ, Helin HJ, Helle MJ and Kallioniemi OP (1990) Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis and mitotic count. Cancer 65: 1180-1184
26. Kallioniemi OP (1988) Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 9: 164-169
27. Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K and Koivula T (1987) Aneuploid DNA content and high S-phase fraction of tumor cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer 23: 277-282
28. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, Lehtinen M and Koivula T (1988) Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA Index and S-phase fraction. Cancer 62: 2183-2190
29. Kamel OW, Franklin WA, Ringus JC and Meyer JS (1989) Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol 134: 107-113
30. Lelle RJ, Heidenreich W, Stauch G and Gerdes J (1986) Bestimmung der Wachstumsfraktion bei Mammakarzinomen mit Hilfe des monoklonalen Antikörpers Ki-67. Tumor Diagnostik und Therapie 7: 181-185
31. Lelle RJ, Heidenreich W, Stauch G and Gerdes J (1987) The correlation of growth fractions with histological grading and lymph node status in human mammary carcinoma. Cancer 59: 83-88
32. McDivitt RW, Stone KR, Craig RB, Palmer JO, Meyer JS and Bauer WC (1986) A proposed classification of breast cancer based un kinetic information. Derived from a comparison of risk factors in 168 primary operable breast cancers. Cancer 57: 269-276
33. O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Rubens RD and Richards MA (1990) Node-negative breast cancer: prognostic subgroups defined by tumour size and flow cytometry. J Clin Oncol 8: 2040-2046
34. Ruschoff J, Neumann K, Contractor H, Plate K and Thomas C (1990) Assessment of nucleolarorganizer regions by automatic image analysis in breast cancer: correlation with DNA content, proliferation rate, receptor status and histopathological grading. J Cancer Res Clin Oncol 116: 480-485
35. Sahin AA, Ro J, Ro JY, Blick MB, El-Naggar AK, Ordonez NG, Flitsche HA, Smith TL, Hortobagyi GN and Ayala AG (1991) Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer 68: 549-557
36. Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D and Olsson H (1990) Indicators of prognosis in node-negative breast cancer. N Engl J Med 322: 1045-1053
37. Toikkanen S, Joensuu H and Klemi P (1989) The prognostic significance of nuclear DNA content in invasive breast cancer - a study with long-term follow-up. Br J Cancer 60: 693-700
38. Verheijen R, Kuijpers HJ, van Driel R, Beck JL, van Dierendorck JH, Brakenhoff GJ and Ramackens FC (1989) Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localisation in mitotic cells and association with chromosomes. J Cell Sci 92: 531-540
39. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M and Lampertico P (1993) Proliferation index as a prognostic marker in breast cancer. Cancer 71: 3926-3931
40. Vielh P, Chevillard S, Mosseri V, Donatini B and Magdelenal H (1990) Ki-67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors. Am J Clin Pathol 94: 681-686
41. Weaver DL, Bagwell CB, Hitchcox SA, Whetstone SD, Baker DR, Herbert DJ and Jones MA (1990) Improved flow cytometric determination of proliferative activity (S-phase fraction) from paraffin-embedded tissue. Am J Clin Pathol 94: 576-584
42. Weidner N, Moore DH and Vartanian R (1994) Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel 'paraffin'-reactive MIB1 antibody. Hum Pathol 25: 337-342